Literature DB >> 11085343

Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs.

H L Koh1, S O Woo.   

Abstract

Traditional Chinese medicine (TCM) is gaining popularity as a form of complementary and alternative medicine. Reports of efficacy of TCM are increasing in numbers. TCM includes both crude Chinese medicinal materials (plants, animal parts and minerals) and Chinese proprietary medicine (CPM) [final dosage forms]. Despite the belief that CPM and herbal remedies are of natural origin, unlike Western medicine, and are hence safe and without many adverse effects, there have been numerous reports of adverse effects associated with herbal remedies. Factors affecting the safety of herbal medicines include intrinsic toxicity, adulteration, substitution, contamination, misidentification, lack of standardisation, incorrect preparation and/or dosage and inappropriate labelling and/or advertising. Hence, new regulations on the control of CPM were enforced in Singapore with effect from 1 September 1999. These include licensing and labelling requirements, as well as control of microbial contamination. This article also reviews reports of excessive toxic heavy metals and undeclared drugs in CPM in Singapore between 1990 and 1997. The names, uses, toxic heavy metal or drug detected and the year of detection are tabulated. Information on the brand or manufacturer's name are provided whenever available. The public and healthcare professionals should be better informed of the basic concept of TCM and its usefulness, as well as the potential adverse effects associated with its use. Greater control over the safety and quality of CPM could be achieved through good manufacturing practice, regulatory control, research, education, reporting usage of Chinese medicine (as in drug history) as well as reporting of adverse events.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085343     DOI: 10.2165/00002018-200023050-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.228


  30 in total

Review 1.  Causes, epidemiology, and clinical evaluation of suspected herbal poisoning.

Authors:  R J Ko
Journal:  J Toxicol Clin Toxicol       Date:  1999

Review 2.  Safety issues with herbal products.

Authors:  C M Marrone
Journal:  Ann Pharmacother       Date:  1999-12       Impact factor: 3.154

Review 3.  [A survey of adverse effects of Chinese herbal drugs in China, 1915-1990].

Authors:  S Du; F Cao; S Lei
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  1992-07

Review 4.  Safety issues in herbal medicine: implications for the health professions.

Authors:  A K Drew; S P Myers
Journal:  Med J Aust       Date:  1997-05-19       Impact factor: 7.738

5.  Lead poisoning from contaminated opium.

Authors:  B L Chia; C K Leng; F P Hsii; M H Yap; Y K Lee
Journal:  Br Med J       Date:  1973-02-10

6.  Lead encephalopathy due to herbal medicine.

Authors:  E C Yu; C Y Yeung
Journal:  Chin Med J (Engl)       Date:  1987-11       Impact factor: 2.628

Review 7.  White paper on herbal products. American College of Clinical Pharmacy.

Authors:  L G Miller; A Hume; I M Harris; E A Jackson; T J Kanmaz; J S Cauffield; T W Chin; M Knell
Journal:  Pharmacotherapy       Date:  2000-07       Impact factor: 4.705

8.  Acute hepatitis associated with the Chinese herbal product jin bu huan.

Authors:  G M Woolf; L M Petrovic; S E Rojter; S Wainwright; F G Villamil; W N Katkov; P Michieletti; I R Wanless; F R Stermitz; J J Beck; J M Vierling
Journal:  Ann Intern Med       Date:  1994-11-15       Impact factor: 25.391

9.  Prevalence and cost of alternative medicine in Australia.

Authors:  A H MacLennan; D H Wilson; A W Taylor
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

10.  Arsenic poisoning from anti-asthmatic herbal preparations.

Authors:  C H Tay; C S Seah
Journal:  Med J Aust       Date:  1975-09-13       Impact factor: 7.738

View more
  21 in total

Review 1.  The use and safety of non-allopathic Indian medicines.

Authors:  N J Gogtay; H A Bhatt; S S Dalvi; N A Kshirsagar
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong.

Authors:  Chor Kwan Ching; Sammy Pak Lam Chen; Hencher Han Chih Lee; Ying Hoo Lam; Sau Wah Ng; Mo Lung Chen; Magdalene Huen Yin Tang; Suzanne Suk San Chan; Candy Wai Yan Ng; Jana Wing Lan Cheung; Tina Yee Ching Chan; Nike Kwai Cheung Lau; Yeow Kuan Chong; Tony Wing Lai Mak
Journal:  Br J Clin Pharmacol       Date:  2017-10-04       Impact factor: 4.335

3.  Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.

Authors:  Victor J Navarro; Huiman Barnhart; Herbert L Bonkovsky; Timothy Davern; Robert J Fontana; Lafaine Grant; K Rajender Reddy; Leonard B Seeff; Jose Serrano; Averell H Sherker; Andrew Stolz; Jayant Talwalkar; Maricruz Vega; Raj Vuppalanchi
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

4.  Heavy metal and pesticide content in commonly prescribed individual raw Chinese Herbal Medicines.

Authors:  Eric S J Harris; Shugeng Cao; Bruce A Littlefield; Jane A Craycroft; Robert Scholten; Ted Kaptchuk; Yanling Fu; Wenquan Wang; Yong Liu; Hubiao Chen; Zhongzhen Zhao; Jon Clardy; Alan D Woolf; David M Eisenberg
Journal:  Sci Total Environ       Date:  2011-08-06       Impact factor: 7.963

5.  Estimation of calcium, magnesium, cadmium, and lead in biological samples from paralyzed quality control and production steel mill workers.

Authors:  Hassan Imran Afridi; Farah Naz Talpur; Tasneem Gul Kazi; Naveed Kazi; Sadaf Sadia Arain; Faheem Shah
Journal:  Environ Monit Assess       Date:  2015-05-14       Impact factor: 2.513

6.  Cadmium accumulation in Panax notoginseng: levels, affecting factors and the non-carcinogenic health risk.

Authors:  Meilin Zhu; Yang Jiang; Bin Cui; Yanxue Jiang; Hongbin Cao; Wensheng Zhang
Journal:  Environ Geochem Health       Date:  2015-06-13       Impact factor: 4.609

7.  Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Authors:  Yan Li; Hu Mei; Qiangen Wu; Suhui Zhang; Jia-Long Fang; Leming Shi; Lei Guo
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

8.  Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions.

Authors:  Darshan H Mehta; Paula M Gardiner; Russell S Phillips; Ellen P McCarthy
Journal:  J Altern Complement Med       Date:  2008-12       Impact factor: 2.579

9.  Assessment of lead and cadmium in fifty-four Indian herbal medicine: tribal and marketed varieties.

Authors:  Arindam Nath; Debika Chakraborty; Suchismita Das
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-11       Impact factor: 4.223

10.  Integrating herbs and supplements in managed care: a pharmacy perspective.

Authors:  Charles Elder; Pat Mossbrucker; Carrie M Davino-Ramaya; Ileana Bez; Margaret M Lin; Theresa A Terry; Emily A Thomas; Sean Jones
Journal:  Perm J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.